India ▾

Mutual fund · Sectoral / Thematic· NAV-verified

Nippon India Pharma Fund

₹9,166 cr across 36 positions, as filed for 2026-09-30. Returns are the fund's AMFI growth-plan NAV; holdings and behavior come from its filed monthly portfolios.

Returns, against the category

Q2 FY27: +13% over 1 year against the median Sectoral / Thematic fund's +2%.

OverQuarter1 year3 years (ann.)5 years (ann.)
Nippon India Pharma Fund0%+13%+17%+13%
Median Sectoral / Thematic fund−2%+2%+12%+11%

1-year return at each quarter-end since Q3 FY24:

+39%Q3 FY24+58%Q4 FY24+41%Q1 FY25+48%Q2 FY25+34%Q3 FY25+12%Q4 FY25+16%Q1 FY26−5%Q2 FY26−3%Q3 FY26+2%Q4 FY26+7%Q1 FY27+13%Q2 FY27

What moved the fund, last 12 filed months

Contribution = the fund's filed weight each month × that stock's price move in its own filings, in percentage points of NAV. Corporate-action months are left out.

Helped

Stock12 monthsLatest month
Divi's Laboratories Limited+2.8 pp−0.1 pp
Sai Life Sciences Limited+2.1 pp+0.2 pp
Sun Pharmaceutical Industries Limited+1.9 pp−1.0 pp
Ajanta Pharma Limited+1.3 pp+0.0 pp
Vijaya Diagnostic Centre Limited+1.3 pp−0.1 pp

Hurt

Stock12 monthsLatest month
Cipla Limited−1.0 pp−0.3 pp
MedPlus Health Services Limited−0.7 pp−0.1 pp
Syngene International Limited−0.6 pp−0.1 pp
Sanofi India Limited−0.6 pp−0.0 pp
Max Healthcare Institute Limited−0.5 pp−0.3 pp

Holdings, as filed for 2026-09-30

HoldingSector% of fundValueHeld forVs avg cost
Sun Pharmaceutical Industries LimitedHealthcare11.71%₹1,073 cr169 mo+293%
Divi's Laboratories LimitedHealthcare7.10%₹651 cr169 mo+213%
Lupin LimitedHealthcare6.17%₹565 cr169 mo+83%
Cipla LimitedHealthcare6.01%₹551 cr169 mo+58%
Dr. Reddy's Laboratories LimitedHealthcare5.45%₹499 cr169 mo+26%
Apollo Hospitals Enterprise LimitedHealthcare4.89%₹448 cr72 mo+85%
Mankind Pharma LimitedHealthcare4.38%₹401 cr42 mo+30%
Sai LifeHealthcare3.92%₹359 cr22 mo+107%
Ajanta Pharma LimitedHealthcare3.61%₹331 cr54 mo+171%
GlaxoSmithKline Pharmaceuticals LimitedHealthcare3.11%₹285 cr50 mo+47%
IPCA Laboratories LimitedHealthcare2.87%₹263 cr23 mo+35%
Max Healthcare Institute LimitedHealthcare2.70%₹247 cr12 mo-15%
Vijaya Diagnostic Centre LimitedHealthcare2.62%₹240 cr61 mo+199%
Gland Pharma LimitedHealthcare2.53%₹232 cr71 mo+68%
Medplus Health Services LimitedConsumer Services2.53%₹232 cr47 mo-13%

Top 15 of 36 equity positions. "Vs avg cost" estimates the fund's gain on the position from its filing history.

How this fund actually behaves

Computed from every filed monthly portfolio (169 months of filings) by the research pipeline.

Holding patienceMedian months a position is held (25th–75th band)50 mo (26–60)
Win rate on exitsClosed positions sold above entry, and the payoff ratio (9 exits)— · payoff —
Loser handlingCuts losers vs averages down, from 12 months of filingsSample too small
Entry valuation disciplineMedian P/E paid on entries over 36 months; share above 50×75× · 77% over 50×
Portfolio valuation todayWeighted P/E and P/B of the current book at filed prices61.3× P/E · 10.0× P/B · 2% loss-makers
ChurnStocks entered and exited in 12 months, of 36 positions3 in · 4 out
ConcentrationTop 10 holdings' share; effective number of positions56% · ~21 effective